Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.006 | 0.0283 | 0.0283 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0625 | 0.4047 | 0.4034 |
Echinococcus multilocularis | protein patched | 0.0625 | 0.4047 | 0.4034 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0625 | 0.4047 | 0.4034 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.0022 | 0.0022 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.0022 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.0022 | 0.5 |
Echinococcus multilocularis | protein dispatched 1 | 0.0625 | 0.4047 | 0.4034 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0337 |
Loa Loa (eye worm) | hypothetical protein | 0.0625 | 0.4047 | 0.4047 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0625 | 0.4047 | 0.4034 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0065 | 0.0312 | 0.0291 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0625 | 0.4047 | 0.8738 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0316 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.0022 | 0.0022 |
Schistosoma mansoni | patched 1 | 0.0625 | 0.4047 | 0.4034 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0068 | 0.0337 | 0.0316 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0065 | 0.0312 | 0.0312 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0712 | 0.4628 | 1 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.1517 | 1 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0337 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0068 | 0.0337 | 0.0316 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.0712 | 0.4628 | 1 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0625 | 0.4047 | 0.4034 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0068 | 0.0337 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0022 | 0.5 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0065 | 0.0312 | 0.0291 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0022 | 0.0022 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0625 | 0.4047 | 0.4047 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.0022 | 0.5 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0625 | 0.4047 | 0.4034 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0068 | 0.0337 | 1 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0065 | 0.0312 | 0.0312 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.1517 | 1 | 1 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.1517 | 1 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0021 | 0.0022 | 0.0022 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0.0022 | 0.0022 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0065 | 0.0312 | 0.0291 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.1517 | 1 | 1 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.1517 | 1 | 1 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.1517 | 1 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0068 | 0.0337 | 0.0337 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.1517 | 1 | 1 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0022 | 0.0022 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.1517 | 1 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0778 | 0.507 | 0.5059 |
Brugia malayi | CHE-14 protein | 0.0625 | 0.4047 | 0.4047 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0712 | 0.4628 | 1 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0712 | 0.4628 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0316 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0065 | 0.0312 | 0.0312 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0778 | 0.507 | 0.5059 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0065 | 0.0312 | 0.92 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0065 | 0.0312 | 0.0312 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.0022 | 0.0022 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0022 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0337 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0778 | 0.507 | 0.5059 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0625 | 0.4047 | 0.4034 |
Loa Loa (eye worm) | hypothetical protein | 0.1517 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 40 uM | Cytotoxicity against human HL60 cells after 72 hrs by MTT assay | ChEMBL. | 20666364 |
IC50 (functional) | > 40 uM | Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay | ChEMBL. | 20666364 |
IC50 (functional) | > 40 uM | Cytotoxicity against human A549 cells after 72 hrs by MTT assay | ChEMBL. | 20666364 |
IC50 (functional) | > 40 uM | Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay | ChEMBL. | 20666364 |
IC50 (functional) | > 40 uM | Cytotoxicity against human SW480 cells after 72 hrs by MTT assay | ChEMBL. | 20666364 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.